Skip to main content
. 2018 May 29;9:727. doi: 10.3389/fimmu.2018.00727

Figure 11.

Figure 11

Schematic representation of dendritic cell vaccine treatment PD-1+ or PD-1 cytotoxic T cells in the peripheral blood arrive at lymph nodes for antigen activation after vaccination. After reaching the tumor microenvironment, the efficiency of tumor cell killing by cytotoxic T cells is determined by the proportion of PD-1+ cytotoxic T cells.